On Thursday, Shares of Array Biopharma Inc (NASDAQ:ARRY), gained 2.12% to $6.75.
Array BioPharma’s, wholly-owned RAF inhibitor, encorafenib, was showcased this past weekend at the 2015 ESMO World Congress of Gastrointestinal Cancer during an oral presentation. At the meeting, data were shared from a Phase 1b trial and preliminary data from a 100-patient randomized Phase 2 expansion of that trial testing the combination of encorafenib and cetuximab, an EGFR inhibitor, with or without the addition of alpelisib (BYL719) 1, an investigational PI3K inhibitor in patients with BRAF-mutant colorectal cancer (BRAFmut CRC). Results from the study indicate that these combinations can be administered with good tolerability and show promising clinical activity in this patient population with high unmet medical needs. Patient enrollment is now complete in the Phase 2 study.
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific.
Shares of Vantiv Inc (NYSE:VNTV), inclined 1.12% to $38.75, during its last trading session.
Vantiv, declared that it will host a conference call to talk about its second quarter 2015 financial results on Wednesday, July 29 at 8:30 a.m. EDT. A press release with second quarter 2015 financial results will be issued at about 7:00 a.m. EDT that same day.
Vantiv, Inc., through its partner, Vantiv Holding, LLC. provides payment processing services in the United States. It operates through two segments, Merchant Services and Financial Institution Services.
At the end of Thursday’s trade, Shares of Kandi Technologies Group Inc (NASDAQ:KNDI), gained 6.11% to $ 5.81.
Kandi Technologies Group, declared that Kandi Electric Vehicles Group Co., Ltd., the manufacturer of Kandi Brand electric vehicles, has received a payment of RMB 271.1 million (about US$44.3 million) representing a national subsidy for pure EV sales during the third and fourth quarter of 2014. The JV Company is a 50/50 joint venture between Kandi and Geely Automobile.
Mr. Hu Xiaoming, Chairman and Chief Executive Officer of Kandi, commented “We are very happy to receive the national government’s subsidy payment for vehicle sales in the second half of 2014. Kandi accomplished the year ranked No. 1 in China in pure electric vehicle sales and production figures. Given the national government’s strong financial support, the growing demand for renewable energy vehicles, and the resulting rapid industry expansion, we believe the Kandi brand will continue to lead the market in pure electric vehicle production and sales growth in China.”
Kandi Technologies Group, Inc., through its auxiliaries, designs, develops, manufactures, and commercializes electric vehicles (EVs), EV parts, and off-road vehicles in the People’s Republic of China and internationally.
Finally, IMAX Corporation (USA) (NYSE:IMAX), remained flat at $29.06.
IMAX Corporation declared that Pixels, the action-comedy starring Adam Sandler, directed by Chris Columbus, and produced by Happy Madison Productions and 1492 Pictures, will be digitally re-mastered into the immersive IMAX 3D format and released into select IMAX theatres domestically on July 24. The film will also be released in select overseas IMAX theatres in conjunction with their wide international release dates.
Together with Sandler, the film also stars Kevin James, Peter Dinklage, Josh Gad and Michelle Monaghan.
IMAX Corporation, together with its auxiliaries, operates as an entertainment technology company specializing in motion picture technologies and presentations worldwide. The company operates in seven segments: IMAX Systems, Theater System Maintenance, Joint Revenue Sharing Arrangements, Film Production and IMAX Digital Re-Mastering (DMR), Film Distribution, Film Post-Production, and Other.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
